EdgeRock Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,198
Closed -$94.3K 201
2024
Q2
$94.3K Buy
+1,198
New +$98.2K 0.07% 75
2024
Q1
Sell
-931
Closed -$81.6K 222
2023
Q4
$81.6K Buy
+931
New +$71K 0.06% 82
2022
Q4
Sell
-23
Closed -$2K 252
2022
Q3
$2K Buy
+23
New +$2.07K ﹤0.01% 311

Other funds holding MDT

EdgeRock Capital's MDT Position: Q3 2024 in Review

EdgeRock Capital sold out of Medtronic (MDT) in Q3 2024, closing a stake of 1,198 shares — an estimated $94.3K sold.

EdgeRock Capital first reported a position in MDT in Q3 2022 and held it in 3 quarters. The position peaked at $94.3K in Q2 2024. 2,063 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • EdgeRock Capital reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • EdgeRock Capital sold 1,198 Medtronic shares in Q3 2024, an estimated $94.3K.
  • EdgeRock Capital first reported a position in Medtronic in Q3 2022 and held it in 3 quarters.
  • EdgeRock Capital's Medtronic position peaked at $94.3K in Q2 2024.
  • 2,063 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on EdgeRock Capital's 13F filing for Q3 2024, filed 15 Oct 2024.